Heart attack drug study halted: Colchicine's nerve protection unclear
NCT ID NCT04420624
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study looked at whether colchicine, a common anti-inflammatory drug, could reduce nerve damage in the heart after a heart attack. It included 54 adults who had a first heart attack and were treated with angioplasty. Participants took colchicine for one month alongside standard care, but the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION, ACUTE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UH Montpellier
Montpellier, 34090, France
Conditions
Explore the condition pages connected to this study.